Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for determining the clinical response to cell therapy

Biomarkers for determining the clinical response to cell therapy

US Patent 10746729 · Granted Aug 18, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mesenchymal stem cell-derived exosomes and their uses2024
Mesenchymal stem cell-derived exosomes and their uses2024
Lymphocyte biomarkers for determining the clinical response to cell therapy2022
Lymphocyte biomarkers for determining the clinical response to cell therapy2022
Lymphocyte biomarkers for determining the clinical response to cell therapy2020
Lymphocyte biomarkers for determining the clinical response to cell therapy2020
Cell populations having immunoregulatory activity, methods for the preparation a2018
Cells, nucleic acid constructs, cells comprising said constructs and methods uti2015
Method to enhance an immune response of nucleic acid vaccination2002
Replication deficient recombinant adenovirus vector2000
Adenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of g2000